Semble
Provides a healthcare management platform that helps outpatient providers manage clinical and administrative workflows.
Overview
Semble builds a healthcare management platform for outpatient providers, serving organizations that need software to run and scale patient-facing operations. Its positioning centers on outpatient care, with a product aimed at supporting management workflows in a specialized healthcare setting. The London-based company raised a $35 million Series C, reported as €34.7 million, in June 2026. The round is intended to help Semble scale its platform, giving it growth capital to expand within the outpatient provider market.
Funding History
London’s Semble raises €34.7 million Series C to scale its healthcare management platform for outpatient providers
Frequently Asked Questions
- How much has Semble raised in total?
- Semble has raised a total of $35M across 1 funding round.
- Who are Semble's investors?
- Semble's investors include Undisclosed.
- What does Semble do?
- Semble builds a healthcare management platform for outpatient providers, serving organizations that need software to run and scale patient-facing operations. Its positioning centers on outpatient care, with a product aimed at supporting management workflows in a specialized healthcare setting. The London-based company raised a $35 million Series C, reported as €34.7 million, in June 2026. The round is intended to help Semble scale its platform, giving it growth capital to expand within the outpatient provider market.
- Where is Semble headquartered?
- Semble is headquartered in London, UK.
Investors
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
Thrive Capital has led funding rounds for OpenAI, Databricks, Perplexity, and Cursor. We analyze the firm's concentrated AI investment strategy and $25B+ portfolio.